Exploring Havas' 'Superwomen' Report on Femtech and Health Equity

The 'Superwomen' Revolution: A Transformative Era in Women's Health

In a groundbreaking move at CES 2025, Havas has released its latest trend intelligence report titled "Superwomen," which addresses the pressing issues of female-centric healthcare. The report delves into the areas where women's health has lagged and outlines a future that promises greater equity and innovative solutions. Historically, women's health has been marginalized, facing significant inequalities in research, representation, and healthcare delivery.

Women are responsible for 80% of healthcare decisions in the U.S., yet only 25% occupy leadership positions in healthcare settings. A staggering 32.4% of participants in clinical trials were women as of 2023. This disparity has contributed to a healthcare system that frequently overlooks the complex and diverse needs of women, often resulting in ineffective solutions for conditions ranging from menstruation to menopause.

The "Superwomen" report emphasizes the need for businesses and brands to address this underrepresented and underfunded market. It showcases the exciting potentials of femtech innovations and presents data that forecasts a $500 billion market growth for women's health technology by 2030.

Key Insights from the Report

Chloe Depiesse, EVP and Head of Digital Strategy at Havas NOW, remarked on the current surge of interest in women's health tech. She noted that this new wave of innovation and investment can be attributed to an influx of venture capital funding, alongside a fresh generation of female entrepreneurs and investors. Celebrities are also raising awareness around women's health issues, creating a more informed and empowered consumer base ready to demand change.

The report outlines four pivotal themes marking the new era of women's healthcare:

1. Super-Optimized Her: This theme addresses how emerging technologies and healthcare innovations are enhancing women's health journeys, promoting longer and healthier lives.

2. GLP-1 Ecosystem: GLP-1 medications are reshaping the management of chronic diseases, providing solutions that extend beyond weight loss. It highlights their role in managing conditions such as PCOS and menopause, and addresses fitness and nutrition programs tailored to this population.

3. The Chief Medical Officer: Focused on the role of women as leading health decision-makers for their families, this section emphasizes the rise of advanced diagnostic tools and telehealth platforms that empower women to take charge of their health.

4. Welltainment℠— Her Queue: This theme explores how brands and influencers are working to democratize healthcare knowledge, making health information and resources more accessible to women.

Eric Weisberg, Global Chief Creative Officer at Havas Health Network, stated, "'Superwomen' isn't solely about innovation—it's about fostering equity and reimagining the narrative of women's healthcare." The report champions the ability of technology and data to provide women with more control over their health, encouraging them to hold healthcare providers accountable.

Conclusion

With its insightful findings, the "Superwomen" report illuminates the urgent need for brands to align with the ever-evolving needs of women. As we shift towards a more equitable health landscape, organizations must actively contribute to transformation within this sphere. Havas Health stands at the forefront of this effort, encouraging collaboration among stakeholders to better serve women and ensure their well-being.

For those wishing to consult the complete "Superwomen" report, it is available for download on the Havas Health website. Stay updated with Havas Health by following them on social media platforms such as Instagram and LinkedIn for the latest research insights and trends.